
- Volume 0 0
 
HRT and Alzheimer's Disease
The bad news is that hormone replacement therapy (HRT) may increase the likelihood of breast cancer in postmenopausal women. The good news, according to the results of a study published in the Journal of the American Medical Association (November 6, 2002), is that women who have taken HRT for at least 10 years are 2.5 times less likely to develop Alzheimer?s disease than non-HRT women.
The following are 2 other key points from this study: First, there was no benefit unless HRT had been begun several years before the onset of mental decline. Second, vitamin and calcium supplements had no effect on Alzheimer?s disease risk.
Articles in this issue
almost 23 years ago
Pharmacist Shares Liability for Home Care Mishapalmost 23 years ago
Taking Stock of the Family Medicine Cabinetalmost 23 years ago
Recognizing Depression and the "Blues": A Pharmacist's Guidealmost 23 years ago
Nurse Diversion in Health Facilities?Part IIalmost 23 years ago
What Older Americans Need to Know About Alzheimer's Diseasealmost 23 years ago
Preparing for E-Prescribingalmost 23 years ago
Ankylosing Spondylitisalmost 23 years ago
Alarming Numbersalmost 23 years ago
"Magic Bracelet"almost 23 years ago
It May Not Be Carpal TunnelNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.














































































































































































































